Search this site
 

Welcome to Acton Biotech, a new diagnostics laboratory dedicated to patient genetics. 
 
We are all different and these differences are because of our genes. Thanks to the Human Genome Project, today it is possible to study a person's genes. We are bringing the benefits of genetics testing to cancer patients in India. Genetic tests helps in selecting the right drug and right dose for every patient so that there are maximum benefits and least side effects. The study of these genetic differences to predict drug response is called Pharmacogenomics or Personalizing Medicines.

We have created the first and only laboratory dedicated to offering pharmacogenomic tests to cancer patients in India. Currently we are offering tests to identify patients who will benefit from Cetuximab, Gefitinib, 5 Fluorouracil, Capecitabine, Tamoxifen, Cisplatin, Oxaliplatin and are at great risk of developing severe toxicity from 6 Mercaptopurine, Methotrexate, Irinotecan and Warfarin. We work hand in hand with leading oncologists and Haematologists across India to make sure that cure is effective, faster and cheaper.

We collect samples from all over India and analyze them in our laboratory. Gradually we will extend our services to all cancer drugs and then move on to drugs used in other diseases like Asthma, Diabetes, TB, AIDS, Cardiovascular and CNS disorders.

Our session at Indian Science Congress was covered by Mathrubhumi (the leading
Malayalam news papers) on 7th Jan on Page 13


And Telegraph on 11th Jan (Read the online version here)